TREACE MEDICAL CONCEPTS, INC. — Director's Dealing 2023

Nov 4, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TREACE MEDICAL CONCEPTS, INC. (TMCI)
CIK: 0001630627
Period of Report: 2023-11-02

Reporting Person: Elder Scot Michael (*See "Remarks")

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-02	Common Stock	F	609	$0.00	Disposed	48910	Direct

Footnotes

F1: Includes 44,632 RSUs.